These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 29537310)

  • 1. Generation, clearance, toxicity, and monitoring possibilities of unaccounted uremic toxins for improved dialysis prescriptions.
    Atherton JG; Hains DS; Bissler J; Pendley BD; Lindner E
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F890-F902. PubMed ID: 29537310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients.
    Huang WH; Hung CC; Yang CW; Huang JY
    Ther Apher Dial; 2012 Aug; 16(4):361-7. PubMed ID: 22817125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The uremic toxin, indoxyl sulfate, signifies cardio-renal risk and intestinal-renal relationship].
    Kiss I
    Orv Hetil; 2011 Oct; 152(43):1724-30. PubMed ID: 21983398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P
    Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
    Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into uremic toxicity.
    Raff AC; Meyer TW; Hostetter TH
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):560-5. PubMed ID: 18941347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An LC-MS/MS analytical method for the determination of uremic toxins in patients with end-stage renal disease.
    Ma YR; Xin MY; Li K; Wang H; Rao Z; Liu TX; Wu XA
    J Pharm Biomed Anal; 2020 Nov; 191():113551. PubMed ID: 32889350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic Toxin Clearance and Cardiovascular Toxicities.
    Mair RD; Sirich TL; Meyer TW
    Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29865226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual renal function: a paradigm shift.
    Lowenstein J; Grantham JJ
    Kidney Int; 2017 Mar; 91(3):561-565. PubMed ID: 28202171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uremic toxins: a new focus on an old subject.
    Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
    Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis.
    Pham NM; Recht NS; Hostetter TH; Meyer TW
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):85-90. PubMed ID: 18045861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Levels and Removal by Haemodialysis and Haemodiafiltration of Tryptophan-Derived Uremic Toxins in ESKD Patients.
    Paats J; Adoberg A; Arund J; Dhondt A; Fernström A; Fridolin I; Glorieux G; Leis L; Luman M; Gonzalez-Parra E; Perez-Gomez VM; Pilt K; Sanchez-Ospina D; Segelmark M; Uhlin F; Arduan Ortiz A
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Uremic Score Reflecting Accumulation of Specific Uremic Toxins More Precisely Predicts One-Year Mortality after Hemodialysis Commencement: A Retrospective Cohort Study.
    Arai Y; Shioji S; Tanaka H; Katagiri D; Hinoshita F
    Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33019590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative inhibitory effects of uremic toxins and other serum components on OATP1B1-mediated transport of SN-38.
    Katsube Y; Tsujimoto M; Koide H; Ochiai M; Hojyo A; Ogawa K; Kambara K; Torii N; Shima D; Furukubo T; Izumi S; Yamakawa T; Minegaki T; Nishiguchi K
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):783-789. PubMed ID: 28314987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
    Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
    Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adsorption- and Displacement-Based Approaches for the Removal of Protein-Bound Uremic Toxins.
    Rodrigues FSC; Faria M
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-bound uremic solutes: the forgotten toxins.
    Vanholder R; De Smet R; Lameire N
    Kidney Int Suppl; 2001 Feb; 78():S266-70. PubMed ID: 11169024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should dialysis modalities be designed to remove specific uremic toxins?
    Baurmeister U; Vienken J; Ward RA
    Semin Dial; 2009; 22(4):454-7. PubMed ID: 19709001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uremic toxins and oral adsorbents.
    Goto S; Yoshiya K; Kita T; Fujii H; Fukagawa M
    Ther Apher Dial; 2011 Apr; 15(2):132-4. PubMed ID: 21426503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update of uremic toxin research by mass spectrometry.
    Niwa T
    Mass Spectrom Rev; 2011; 30(3):510-21. PubMed ID: 21328600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibuprofen-Immobilized Thin Films: A Novel Approach to Improve the Clearance of Protein-Bound Uremic Toxins.
    Rodrigues FSC; Brilhante D; Macêdo A; Pires RF; Faria M
    ACS Appl Mater Interfaces; 2024 Feb; 16(5):6589-6604. PubMed ID: 38282580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.